Vol.

No.

March 20, 2026Mar 20, 2026

DOWNLOAD THE PDF

Hoping to hit a $200M target, NCI and FNIH develop a plan for advancing cancer vaccines NCI Director Letai: “How aggressive can we be?”

Cover Story

NCI

Hoping to hit a $200M target, NCI and FNIH develop a plan for advancing cancer vaccines

NCI Director Letai: “How aggressive can we be?”

By Claire Marie Porter

A public-private effort, spearheaded by NCI Director Anthony Letai, and led by the Foundation for the National Institutes of Health, is working to speed up the development of therapeutic cancer vaccines.

NCI

A new working group will conduct site visits and advise NCAB and NCI director on cancer center grants

By Paul Goldberg

NCI

Letai: “From this point forward, it really is much more like business as usual at the NCI.”

By Jacquelyn Cobb

Early-onset colorectal cancer demands a new research playbook

By Marwan Fakih

Cancer Policy

The reconstitution of ACIP and changes to CDC’s childhood vaccine schedule were likely illegal, judge rules

EPA proposes amendments to weaken emission limits on ethylene oxide

FDA launches consolidated adverse event reporting system

House bill proposes to exempt health care workers from H-1B visa $100,000 fee

In Brief

Robert A. Winn named director of Fox Chase Cancer Center

Robert H. Vonderheide elected as AACR president-elect

AACR elects five members to board of directors

Shadman, Venur named deputy CMOs and endowed chairs at Fred Hutch

Kathleen N. Moore appointed deputy director and director of Phase I Oncology Trials Program at Fred & Pamela Buffett Cancer Center

Washington Research Foundation awards $7M to UW Institute for Protein Design to advance AI-enabled enzyme development

KU Cancer Center deploys new mobile cancer screening bus

Funding Opportunities

SITC seeks applications for two fellowships

Clinical Roundup

Merck to present long-term data of Gardasil 9 and Gardasil at the EUROGIN international multidisciplinary HPV Congress

Atirmociclib combination produces positive topline results in phase II trial in second-line MBC indication

Mayo Clinic researchers use milk-derived nanoparticles to target aggressive bile duct cancer

Computational model measures key aging metric from routine biopsies, Sanford Burnham study finds

Computational biology tool automates and standardizes genome sequencing analysis, Sanford Burnham study finds

Inocras and Broad Institute researchers will release insights from TCGA cancer whole-genome analysis at AACR annual meeting

Drugs & Targets

PanTracer LBx liquid biopsy profiling test receives Medicare coverage

Sartorius launches platform to boost efficiency in cell therapy production

START, Trialing collaborate to expand access to oncology clinical trials across Europe

PREVIOUS ISSUE

NEXT ISSUE

Recent Issues

Volume 52 | Issue 35 - September 25, 2026